Characterization of naturally occurring HPV16 integration sites isolated from cervical keratinocytes under noncompetitive conditions

Cancer Research

Volumn 68, Issue 20, 2008, Pages 8249-8259

  Dall, Keltie L ^a   Scarpini, Cinzia G ^a   Roberts, Ian ^a   Winder, David M ^a   Stanley, Margaret A ^a   Muralidhar, Balaji ^a   Herdman, M Trent ^a   Pett, Mark R ^a   Coleman, Nicholas ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ARTICLE; CANCER MODEL; CARCINOGENESIS; CELL ISOLATION; CELL POPULATION; CELLULAR DISTRIBUTION; CHROMOSOME BAND; CONTROLLED STUDY; DNA RECOMBINATION; EPISOME; FEMALE; GENE EXPRESSION; GENE INSERTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; ONCOGENE; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX; VIRUS DNA CELL DNA INTERACTION;

CELLS, CULTURED; CERVIX UTERI; CHROMOSOME FRAGILE SITES; CHROMOSOME MAPPING; DNA BREAKS, DOUBLE-STRANDED; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; MUTAGENESIS, INSERTIONAL; UTERINE CERVICAL NEOPLASMS; VIRUS INTEGRATION;

EID: 54249105939     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-1741     Document Type: Article

References (47)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
2. Green J, Berrington de Gonzalez A, Sweetland S, et al. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer. Br J Cancer 2003;89:2078-86.
3. Melsheimer P, Vinokurova S, Wentzensen N, Bastert G, von Knebel Doeberitz M. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri. Clin Cancer Res 2004;10:3059-63.
4. Pett M, Coleman N. Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol 2007;212:356-67.
5. Wentzensen N, Vinokurova S, von Knebel Doeberitz M. Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 2004;64:3878-84.
6. Winder DM, Pett MR, Foster N, et al. An increase in DNA double-strand breaks, induced by Ku70 depletion, is associated with human papillomavirus 16 episome loss and de novo viral integration events. J Pathol 2007;213:27-34.
7. Yu T, Ferber MJ, Cheung TH, Chung TK, Wong YF, Smith DI. The role of viral integration in the development of cervical cancer. Cancer Genet Cytogenet 2005;158:27-34.
8. Durkin SG, Glover TW. Chromosome fragile sites. Annu Rev Genet 2007;41:169-92.
9. Popescu NC. Genetic alterations in cancer as a result of breakage at fragile sites. Cancer Lett 2003;192:1-17.
10. Kraus I, Driesch C, Vinokurova S, et al. The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes. Cancer Res 2008;68:2514-22.
11. Thorland EC, Myers SL, Persing DH, et al. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res 2000;60:5916-21.
12. Peter M, Rosty C, Couturier J, Radvanyi F, Teshima H, Sastre-Garau X. MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors. Oncogene 2006;25:5985-93.
13. von Knebel Doeberitz M, Bauknecht T, Bartsch D, zur Hausen H. Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc Natl Acad Sci U S A 1991;88:1411-5.
14. Stanley MA, Browne HM, Appleby M, Minson AC. Properties of a non-tumorigenic human cervical keratinocyte cell line. Int J Cancer 1989;43:672-6.
15. Pett MR, Alazawi WO, Roberts I, et al. Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res 2004;64:1359-68.
16. Pett MR, Herdman MT, Palmer RD, et al. Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc Natl Acad Sci U S A 2006;103:3822-7.
17. Herdman MT, Pett MR, Roberts I, et al. Interferon-β treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants. Carcinogenesis 2006;27:2341-53.
18. Alazawi W, Pett M, Arch B, et al. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Res 2002;62:6959-65.
19. Coleman N, Greenfield IM, Hare J, Kruger-Gray H, Chain BM, Stanley MA. Characterization and functional analysis of the expression of intercellular adhesion molecule-1 in human papillomavirus-related disease of cervical keratinocytes. Am J Pathol 1993;143:355-67.
20. Sarkar G, Turner RT, Bolander ME. Restriction-site PCR: a direct method of unknown sequence retrieval adjacent to a known locus by using universal primers. PCR Methods Appl 1993;2:318-22.
21. Klaes R, Woerner SM, Ridder R, et al. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 1999;59:6132-6.
22. Thorland EC, Myers SL, Gostout BS, Smith DI. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 2003;22:1225-37.
23. Choo KB, Pan CC, Han SH. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 1987;161:259-61.
24. Luft F, Klaes R, Nees M, et al. Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer 2001;92:9-17.
25. Wentzensen N, Ridder R, Klaes R, Vinokurova S, Schaefer U, Doeberitz MK. Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene 2002;21:419-26.
26. Denison SR, Simper RK, Greenbaum IF. How common are common fragile sites in humans: interindividual variation in the distribution of aphidicolin-induced fragile sites. Cytogenet Genome Res 2003;101:8-16.
27. Katsura Y, Sasaki S, Sato M, et al. Involvement of Ku80 in microhomology-mediated end joining for DNA double-strand breaks in vivo . DNA Repair Amst 2007;6:639-48.
28. Kohno T, Yokota J. Molecular processes of chromosome 9p21 deletions causing inactivation of the p16 tumor suppressor gene in human cancer: deduction from structural analysis of breakpoints for deletions. DNA Repair Amst 2006;5:1273-81.
29. Couturier J, Sastre-Garau X, Schneider-Maunoury S, Labib A, Orth G. Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression. J Virol 1991;65:4534-8.
30. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004;101:2999-3004.
31. Suo G, Han J, Wang X, et al. Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun 2005;337:1047-51.
32. Stubenrauch F, Laimins LA. Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol 1999;9:379-86.
33. Remmink AJ, Walboomers JM, Helmerhorst TJ, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995;61:306-11.
34. Helmrich A, Stout-Weider K, Matthaei A, Hermann K, Heiden T, Schrock E. Identification of the human/mouse syntenic common fragile site FRA7K/Fra12C1-relation of FRA7K and other human common fragile sites on chromosome 7 to evolutionary breakpoints. Int J Cancer 2007;120:48-54.
35. Mishmar D, Rahat A, Scherer SW, et al. Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc Natl Acad Sci U S A 1998;95:8141-6.
36. Hormozian F, Schmitt JG, Sagulenko E, Schwab M, Savelyeva L. FRA1E common fragile site breaks map within a 370 kilobase pair region and disrupt the dihydropyrimidine dehydrogenase gene (DPYD). Cancer Lett 2007;246:82-91.
37. Huang H, Qian J, Proffit J, Wilber K, Jenkins R, Smith DI. FRA7G extends over a broad region: coincidence of human endogenous retroviral sequences (HERV-H) and small polydispersed circular DNAs (spcDNA) and fragile sites. Oncogene 1998;16:2311-9.
38. Savelyeva L, Sagulenko E, Schmitt JG, Schwab M. The neurobeachin gene spans the common fragile site FRA13A. Hum Genet 2006;118:551-8.
39. Arlt MF, Miller DE, Beer DG, Glover TW. Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells. Genes Chromosomes Cancer 2002;33:82-92.
40. Sawinska M, Schmitt JG, Sagulenko E, Westermann F, Schwab M, Savelyeva L. Novel aphidicolin-inducible common fragile site FRA9G maps to 9p22.2, within the C9orf39 gene. Genes Chromosomes Cancer 2007;46:991-9.
41. Curatolo A, Limongi ZM, Pelliccia F, Rocchi A. Molecular characterization of the human common fragile site FRA1H. Genes Chromosomes Cancer 2007;46:487-93.
42. Becker NA, Thorland EC, Denison SR, Phillips LA, Smith DI. Evidence that instability within the FRA3B region extends four megabases. Oncogene 2002;21:8713-22.
43. Ziegert C, Wentzensen N, Vinokurova S, et al. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Oncogene 2003;22:3977-84.
44. Herrick J, Conti C, Teissier S, et al. Genomic organization of amplified MYC genes suggests distinct mechanisms of amplification in tumorigenesis. Cancer Res 2005;65:1174-9.
45. Kadaja M, Sumerina A, Verst T, Ojarand M, Ustav E, Ustav M. Genomic instability of the host cell induced by the human papillomavirus replication machinery. Embo J 2007;26:2180-91.
46. Ferber MJ, Thorland EC, Brink AA, et al. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene 2003;22:7233-42.
47. Soh LT, Heng D, Lee IW, Ho TH, Hui KM. The relevance of oncogenes as prognostic markers in cervical cancer. Int J Gynecol Cancer 2002;12:465-74.